Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Thin Film Drug Manufacturing Market Growth From $9.51 Billion In 2026 To $13.35 Billion By 2030 At A CAGR Of 8.9%
The thin film drug manufacturing market size has shown significant growth in recent years. It is anticipated to expand from $8.71 billion in 2025 to $9.51 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.2%. The historical increase in this market can be attributed to factors such as the difficulty patients experience in swallowing conventional tablets, an increasing emphasis on patient compliance, the early adoption of oral dissolving technologies, a rising demand for rapid onset therapies, and the expansion of hospital pharmacy distribution channels.
The thin film drug manufacturing market is anticipated to experience substantial growth over the coming years, with projections indicating an increase to $13.35 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 8.9%. This expansion during the forecast period is fueled by several factors, including developments in thin film formulation technologies, an increase in neurological disorders, the broadening reach of e-commerce for pharmaceutical distribution, greater investment in new drug delivery systems, and a rise in regulatory approvals for thin film drugs. Key trends driving this period include the growing preference for oral thin films for quick drug release, a heightened need for dosage forms that are easier for patients, more widespread use of thin films for neurological and CNS conditions, the development of taste-masked and orodispersible film technologies, and an increase in the use of thin films for treating migraine and opioid dependence.
Get A Free Sample Report With In-Depth Market Insights:
Thin Film Drug Manufacturing Market Growth Factors Behind Sustained Expansion
The global increase in the elderly population is expected to drive the expansion of the thin-film drug manufacturing market moving forward. This rise in the worldwide senior demographic is attributed to factors like extended life expectancies, advancements in medicine, improved nutrition and healthcare, and evolving family structures and societal norms. Thin film drug manufacturing addresses the needs of the growing elderly population by offering improved medication adherence, ease of use, precise dosage control, rapid dissolution, and enhanced stability, all of which contribute to better management of chronic conditions and overall health for older adults. For instance, in January 2024, the Population Reference Bureau, a US-based nonprofit organization, projected that the number of Americans ages 65 and older will increase from 58 million in 2022 to 82 million by 2050. Therefore, the increase in the global elderly population is a key driver for the thin film drug manufacturing market.
Thin Film Drug Manufacturing Market Segment Performance And Emerging Opportunities
The thin film drug manufacturing market covered in this report is segmented –
1) By Type: Oral Thin Film, Transdermal Film, Other Types
2) By Disease Indication: Schizophrenia, Migraine, Opioid Dependence, Nausea And Vomiting, Other Disease Indications
3) By Distribution Channel: Hospital Pharmacies, Drug Stores, Retail Pharmacies, E-Commerce
Subsegments:
1) By Oral Thin Film: SubLingual Films, Buccal Films, Orodispersible Films, Taste-Masked Oral Films
2) By Transdermal Film: Adhesive Transdermal Films, Matrix Transdermal Films, Reservoir Transdermal Films, Drug-Eluting Transdermal Films
3) By Other Types: Topical Films, Ophthalmic Films, Intranasal Films, Veterinary Thin Films
Thin Film Drug Manufacturing Market Industry Trends Fueling Future Revenue Growth
Companies prominent in the thin film drug manufacturing market are concentrating on developing innovative products, such as oral thin film technologies, with the aim of improving patient compliance and user convenience. Oral thin film technologies involve creating films that dissolve rapidly, allowing medication delivery through the mouth’s mucous membranes for swift absorption. These films present a convenient, effective, and easy-to-use alternative to traditional oral dosage forms like tablets and capsules. For example, in April 2023, IntelGenx Corporation, a Canada-based pharmaceutical company, announced the Food and Drug Administration (FDA) approval of RIZAFILM for the treatment of acute migraine. This new formulation enables quick dissolution and absorption, potentially offering faster relief for migraines compared to conventional tablets. This innovation enhances bioavailability and provides a more convenient, user-friendly option, thereby improving patient compliance. The thin film technology significantly boosts patient compliance and ease of use, establishing it as a more accessible alternative for managing acute migraine attacks.
Thin Film Drug Manufacturing Market Key Players: Which Companies Lead Industry Competition?
Major companies operating in the thin film drug manufacturing market are Novartis AG, Merck KGaA, Dr. Reddy’s Laboratories, Indivior PLC, LTS Lohmann Therapie-Systeme AG, Aquestive Therapeutics, Zim Laboratories Ltd, Tapemark, AdhexPharma, MonoSol Rx, Aavishkar Oral Strips Pvt Ltd., APR Applied Pharma Research SA, Cynapsus Therapeutics Inc., Jurata Thin Film Inc., Nova Thin Film Pharmaceuticals LLC, Vektor Pharma TF GmbH, TFF Pharmaceuticals Inc., NAL Pharma, IntelGenx Corp, D.K. Livkon Healthcare Pvt Ltd.
View The Full Thin Film Drug Manufacturing Market Report:
Thin Film Drug Manufacturing Market Regional Outlook: Where Is Opportunity Concentrated?
North America was the largest region in the thin film drug manufacturing market in 2025. The regions covered in the thin film drug manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
